Cerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and Prevention

Moshe Stavsky, Omer Mor, Salvatore Andrea Mastrolia, Shirley Greenbaum, Nandor Gabor Than, Offer Erez, Moshe Stavsky, Omer Mor, Salvatore Andrea Mastrolia, Shirley Greenbaum, Nandor Gabor Than, Offer Erez

Abstract

Cerebral palsy (CP) is the most common motor disability in childhood. This syndrome is the manifestation of intrauterine pathologies, intrapartum complications, and the postnatal sequel, especially among preterm neonates. A double hit model theory is proposed suggesting that an intrauterine condition along with intrapartum or postnatal insult lead to the development of CP. Recent reports demonstrated that treatment during the process of preterm birth such as magnesium sulfate and postnatal modalities such as cooling may prevent or reduce the prevalence of this syndrome. Moreover, animal models demonstrated that postnatal treatment with anti-inflammatory drugs coupled with nanoparticles may affect the course of the disease in pups with neuroinflammation. This review will describe the changes in the epidemiology of this disease, the underlying prenatal mechanisms, and possible treatments that may reduce the prevalence of CP and alter the course of the disease.

Keywords: N-acetyl cysteine; birth asphyxia; cerebral palsy; intrauterine infection; magnesium sulfate; nanoparticles; neuroinflammation; progesterone.

Figures

Figure 1
Figure 1
Underlying mechanisms leading to cerebral palsy (CP). The mechanisms leading to cerebral palsy can be attributed to the following exposures: (1) intrauterine exposure including infection elicit a fetal inflammatory response syndrome and white matter damage in the fetus, fetal growth restriction, placental vascular disorders that are associated with vascular injuries in the fetal brain and congenital anomalies. (2) Intrapartum events that affect the fetus during the process of labor and delivery such as chorioamnionitis, birth asphyxia, and placental abruption are all acute events that are associated with further implication on the fetal/neonatal brain. (3) Post-partum exposure to infection of prematurity complications that affect the neonate and subsequently lead to CP. These events can be isolated but also combined, and the two-hit theory proposed that a neonate who suffered from hostile intrauterine environment such as infection may be further affected by acute intrapartum event such as abruption or post-partum complication and develop CP.
Figure 2
Figure 2
Strategies for the reduction of cerebral palsy (CP). The strategies to reduce the rate of CP are as follows: (1) prevention of adverse events during pregnancy mainly of preterm birth (spontaneous or indicated); (2) the administrations of supportive medical treatment during an acute event such as magnesium sulfate of betamethasone during preterm labor; and (3) postexposure treatment to reduce the neurologic injury.

References

    1. Accardo P, Accardo J, Capute A. A neurodevelopmental perspective on the continuum of developmental disabilities. 3rd ed In: Accardo P, editor. Capute & Accardo’s Neurodevelopmental Disabilities in Infancy and Childhood. Baltimore, MD: Brookes; (2007). p. 3–26.
    1. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, et al. A report: the definition and classification of cerebral palsy. Dev Med Child Neurol Suppl (2007) 109(April):8–14.
    1. Trønnes H, Wilcox AJ, Lie RT, Markestad T, Moster D. Risk of cerebral palsy in relation to pregnancy disorders and preterm birth: a national cohort study. Dev Med Child Neurol (2014) 56(8):779–85.10.1111/dmcn.12430
    1. Grobman WA, Lai Y, Rouse DJ, Spong CY, Varner MW, Mercer BM, et al. The association of cerebral palsy and death with small-for-gestational-age birthweight in preterm neonates by individualized and population-based percentiles. Am J Obstet Gynecol (2013) 209(4):340.e1–5.10.1016/j.ajog.2013.06.007
    1. Blair EM, Nelson KB. Fetal growth restriction and risk of cerebral palsy in singletons born after at least 35 weeks’ gestation. Am J Obstet Gynecol (2015) 212(4):520.e1–7.10.1016/j.ajog.2014.10.1103
    1. Mor O, Stavsky M, Yitshak-Sade M, Mastrolia SA, Beer-Weisel R, Rafaeli-Yehudai T, et al. Early onset preeclampsia and cerebral palsy: a double hit model? Am J Obstet Gynecol (2016) 214(1):105.e1–105.10.1016/j.ajog.2015.08.020
    1. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol (1998) 179(1):194–202.10.1016/S0002-9378(98)70272-8
    1. Yoon BH, Park C-W, Chaiworapongsa T. Intrauterine infection and the development of cerebral palsy. BJOG (2003) 110(s20):124–7.10.1016/S1470-0328(03)00063-6
    1. Mutch L, Alberman E, Hagberg B, Kodama K, Perat MV. Cerebral palsy epidemiology: where are we now and where are we going? Dev Med Child Neurol (2008) 34(6):547–51.10.1111/j.1469-8749.1992.tb11479.x
    1. Arneson CL, Durkin MS, Benedict RE, Kirby RS, Yeargin-Allsopp M, Van Naarden Braun K, et al. Prevalence of cerebral palsy: Autism and Developmental Disabilities Monitoring Network, three sites, United States, 2004. Disabil Health J (2009) 2:45–8.10.1016/j.dhjo.2008.08.001
    1. Bhasin T, Brocksen S, Nonkin Avchen R, Van Naarden Braun K. Prevalence of four developmental disabilities among children aged 8 years – Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1996 and 2000. MMWR Surveill Summ (2006) 55:1–9.
    1. Paneth N, Hong T, Korzeniewski S. The descriptive epidemiology of cerebral palsy. Clin Perinatol (2006) 33(2):251–67.10.1016/j.clp.2006.03.011
    1. Johnson A. Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol (2002) 44(9):633–40.10.1017/S0012162201002675
    1. Winter S, Autry A, Boyle C, Yeargin-Allsopp M. Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics (2002) 110(6):1220–5.10.1542/peds.110.6.1220
    1. Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil (2006) 28(4):183–91.10.1080/09638280500158422
    1. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the “common” neurologic disorders? Neurology (2007) 68(5):326–37.10.1212/01.wnl.0000252807.38124.a3
    1. Oskoui M, Coutinho F, Dykeman J, Jetté N, Pringsheim T. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol (2013) 55(6):509–19.10.1111/dmcn.12080
    1. Van Naarden Braun K, Doernberg N, Schieve L, Christensen D, Goodman A, Yeargin-Allsopp M. Birth prevalence of cerebral palsy: a population-based study. Pediatrics (2016) 137(1).10.1542/peds.2015-2872
    1. Maenner MJ, Blumberg SJ, Kogan MD, Christensen D, Yeargin-Allsopp M, Schieve LA. Prevalence of cerebral palsy and intellectual disability among children identified in two U.S. National Surveys, 2011-2013. Ann Epidemiol (2016) 26:222–6.10.1016/j.annepidem.2016.01.001
    1. Sigurdardottir S, Thorkelsson T, Halldorsdottir M, Thorarensen Ó, Vik T. Trends in prevalence and characteristics of cerebral palsy among Icelandic children born 1990 to 2003. Dev Med Child Neurol (2009) 51(5):356–63.10.1111/j.1469-8749.2009.03303.x
    1. Smithers-Sheedy H, McIntyre S, Gibson C, Meehan E, Scott H, Goldsmith S, et al. A special supplement: findings from the Australian Cerebral Palsy Register, birth years 1993 to 2006. Dev Med Child Neurol (2016) 58(Suppl 2):5–10.10.1111/dmcn.13026
    1. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med (1986) 315(2):81–6.10.1056/NEJM198607103150202
    1. Blair E, Stanley F. When can cerebral palsy be prevented? The generation of causal hypotheses by multivariate analysis of a case-control study. Paediatr Perinat Epidemiol (1993) 7(3):272–301.10.1111/j.1365-3016.1993.tb00405.x
    1. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA (1997) 278(3):207–11.10.1001/jama.278.3.207
    1. Hankins GDV, Speer M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol (2003) 102(3):628–36.10.1097/00006250-200309000-00036
    1. O’Shea TM, Allred EN, Dammann O, Hirtz D, Kuban KCK, Paneth N, et al. The ELGAN study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev (2009) 85(11):719–25.10.1016/j.earlhumdev.2009.08.060
    1. Vincer MJ, Allen AC, Joseph KS, Stinson DA, Scott H, Wood E. Increasing prevalence of cerebral palsy among very preterm infants: a population-based study. Pediatrics (2006) 118(6):e1621–6.10.1542/peds.2006-1522
    1. Ancel P-Y, Livinec F, Larroque B, Marret S, Arnaud C, Pierrat V, et al. Cerebral palsy among very preterm children in relation to gestational age and neonatal ultrasound abnormalities: the EPIPAGE cohort study. Pediatrics (2006) 117(3):828–35.10.1542/peds.2005-0091
    1. Himpens E, Van den Broeck C, Oostra A, Calders P, Vanhaesebrouck P. Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review. Dev Med Child Neurol (2008) 50(5):334–40.10.1111/j.1469-8749.2008.02047.x
    1. Hirvonen M, Ojala R, Korhonen P, Haataja P, Eriksson K, Gissler M, et al. Cerebral palsy among children born moderately and late preterm. Pediatrics (2014) 134(6):e1584–93.10.1542/peds.2014-0945
    1. Moster D, Wilcox AJ, Vollset SE, Markestad T, Lie RT. Cerebral palsy among term and postterm births. JAMA (2010) 304(9):976–82.10.1001/jama.2010.1271
    1. Croen LA, Grether JK, Curry CJ, Nelson KB. Congenital abnormalities among children with cerebral palsy: more evidence for prenatal antecedents. J Pediatr (2001) 138(6):804–10.10.1067/mpd.2001.114473
    1. McIntyre S, Blair E, Badawi N, Keogh J, Nelson KB. Antecedents of cerebral palsy and perinatal death in term and late preterm singletons. Obstet Gynecol (2013) 122(4):869–77.10.1097/AOG.0b013e3182a265ab
    1. Streja E, Miller JE, Wu C, Bech BH, Pedersen LH, Schendel DE, et al. Disproportionate fetal growth and the risk for congenital cerebral palsy in singleton births. PLoS One (2015) 10(5):e0126743.10.1371/journal.pone.0126743
    1. Nelson KB, Blair E. Prenatal factors in singletons with cerebral palsy born at or near term. N Engl J Med (2015) 373:946–53.10.1056/NEJMra1505261
    1. Rankin J, Cans C, Garne E, Colver A, Dolk H, Uldall P, et al. Congenital anomalies in children with cerebral palsy: a population-based record linkage study. Dev Med Child Neurol (2010) 52(4):345–51.10.1111/j.1469-8749.2009.03415.x
    1. Bonellie S, Currie D, Chalmers J. Comparison of risk factors for cerebral palsy in twins and singletons. Dev Med Child Neurol (2005) 47(09):587–91.10.1111/j.1469-8749.2005.tb01208.x
    1. Grether JK, Nelson KB, Cummins SK. Twinning and cerebral palsy: experience in four northern California counties, births 1983 through 1985. Pediatrics (1993) 92(6):854–8.
    1. Scher AI, Petterson B, Blair E, Ellenberg JH, Grether JK, Haan E, et al. The risk of mortality or cerebral palsy in twins: a collaborative population-based study. Pediatr Res (2002) 52(5):671–81.10.1203/00006450-200211000-00011
    1. Petterson B, Nelson KB, Watson L, Stanley F. Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s. BMJ (1993) 307(6914):1239–43.10.1136/bmj.307.6914.1239
    1. Grunt S, Mazenauer L, Buerki SE, Boltshauser E, Mori AC, Datta AN, et al. Incidence and outcomes of symptomatic neonatal arterial ischemic stroke. Pediatrics (2015) 135(5):e1220.10.1542/peds.2014-1520
    1. Gibson CS, MacLennan AH, Hague WM, Haan EA, Priest K, Chan A, et al. Associations between inherited thrombophilias, gestational age, and cerebral palsy. Am J Obstet Gynecol (2005) 193(4):1437.10.1016/j.ajog.2005.02.107
    1. Fattal-Valevski A, Kenet G, Kupferminc MJ, Mesterman R, Leitner Y, Rimon E, et al. Role of thrombophilic risk factors in children with non-stroke cerebral palsy. Thromb Res (2005) 116(2):133–7.10.1016/j.thromres.2004.11.022
    1. Costeff H. Estimated frequency of genetic and nongenetic causes of congenital idiopathic cerebral palsy in West Sweden. Ann Hum Genet (2004) 68(5):515–20.10.1046/j.1529-8817.2004.00105.x
    1. Nelson KB, Dambrosia JM, Iovannisci DM, Cheng S, Grether JK, Lammer E. Genetic polymorphisms and cerebral palsy in very preterm infants. Pediatr Res (2005) 57(4):494–9.10.1203/01.PDR.0000156477.00386.E7
    1. Gibson CS, MacLennan AH, Goldwater PN, Haan EA, Priest K, Dekker GA, et al. The association between inherited cytokine polymorphisms and cerebral palsy. Am J Obstet Gynecol (2006) 194(3):674.e1–e11.10.1016/j.ajog.2006.01.093
    1. Gibson CS, Maclennan AH, Dekker GA, Goldwater PN, Sullivan TR, Munroe DJ, et al. Candidate genes and cerebral palsy: a population-based study. Pediatrics (2008) 122(5):1079–85.10.1542/peds.2007-3758
    1. McHale DP, Mitchell S, Bundey S, Moynihan L, Campbell DA, Woods CG, et al. A gene for autosomal recessive symmetrical spastic cerebral palsy maps to chromosome 2q24-25. Am J Hum Genet (1999) 64(2):526–32.10.1086/302237
    1. Verkerk AJMH, Schot R, Dumee B, Schellekens K, Swagemakers S, Bertoli-Avella AM, et al. Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. Am J Hum Genet (2009) 85(1):40–52.10.1016/j.ajhg.2009.06.004
    1. Mchale D, Jackson A, Campbell D, Levene M, Corry P, Woods C, et al. A gene for ataxic cerebral palsy maps to chromosome 9p12–q12. Eur J Hum Genet (2000) 8:267–72.10.1038/sj.ejhg.5200445
    1. Lerer I, Sagi M, Meiner V, Cohen T, Zlotogora J, Abeliovich D. Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy. Hum Mol Genet (2005) 14(24):3911–20.10.1093/hmg/ddi415
    1. Paz D, Schreiber L, Erez O, Ziskind S, Richardson J, Staretz O, et al. Inflammatory and vascular placental lesions are associated with neonatal amplitude integrated EEG recording in early premature neonates. Proceedings of the 63rd Annual Scientific Meeting of the Society of Reproductive Investigation Montreal (2016). p. 0–148.
    1. Redline RW, Minich N, Taylor HG, Hack M. Placental lesions as predictors of cerebral palsy and abnormal neurocognitive function at school age in extremely low birth weight infants (<1kg). Pediatr Dev Pathol (2007) 10(4):282–92.10.2350/06-12-0203.1
    1. Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi J-H, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol (2000) 182(3):675–81.10.1067/mob.2000.104207
    1. Saadani-Makki F, Kannan S, Lu X, Janisse J, Dawe E, Edwin S, et al. Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy. Am J Obstet Gynecol (2008) 199(6):651.e1–7.10.1016/j.ajog.2008.06.090
    1. Romero R, Gotsch F, Mazaki-Tovi S, Kusanovic JP. Inflammation and infection. 1st ed In: Berghella V, editor. Preterm Birth: Prevention and Management. Oxford: Wiley-Blackwell; (2010). p. 57–77.
    1. Gonçalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev (2002) 8(1):3–13.10.1002/mrdd.10008
    1. Romero R, Nores J, Mazor M, Sepulveda W, Oyarzun E, Parra M, et al. Microbial invasion of the amniotic cavity during term labor. Prevalence and clinical significance. J Reprod Med (1993) 38(7):543–8.
    1. Shim S-S, Romero R, Hong J-S, Park C-W, Jun JK, Kim BI, et al. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol (2004) 191:1339–45.10.1016/j.ajog.2004.06.085
    1. Romero R, Savasan ZA, Chaiworapongsa T, Berry SM, Kusanovic JP, Hassan SS, et al. Hematologic profile of the fetus with systemic inflammatory response syndrome. J Perinat Med (2012) 40(1):19–32.10.1515/JPM.2011.100
    1. Chaiworapongsa T, Romero R, Berry SM, Hassan SS, Yoon BH, Edwin S, et al. The role of granulocyte colony-stimulating factor in the neutrophilia observed in the fetal inflammatory response syndrome. J Perinat Med (2011) 39(6):653–66.10.1515/JPM.2011.072
    1. Di Naro E, Cromi A, Ghezzi F, Raio L, Uccella S, D’Addario V, et al. Fetal thymic involution: a sonographic marker of the fetal inflammatory response syndrome. Am J Obstet Gynecol (2006) 194(1):153–9.10.1016/j.ajog.2005.05.036
    1. Hyun Yoon B, Romero R, Kwan Jun J, Maymon E, Gomez R, Mazor M, et al. An increase in fetal plasma cortisol but not dehydroepiandrosterone sulfate is followed by the onset of preterm labor in patients with preterm premature rupture of the membranes. Am J Obstet Gynecol (1998) 179(5):1107–14.10.1016/S0002-9378(98)70114-0
    1. Romero R, Espinoza J, Gonçalves LF, Gomez R, Medina L, Silva M, et al. Fetal cardiac dysfunction in preterm premature rupture of membranes. J Matern Fetal Neonatal Med (2004) 16:146–57.10.1080/14767050400009279
    1. Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol (2007) 50(3):652–83.10.1097/GRF.0b013e31811ebef6
    1. Kadhim H, Tabarki B, De Prez C, Sébire G. Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy? Acta Neuropathol (2003) 105(3):209–16.
    1. Deguchi K, Oguchi K, Takashima S. Characteristic neuropathology of leukomalacia in extremely low birth weight infants. Pediatr Neurol (1997) 16(4):296–300.10.1016/S0887-8994(97)00041-6
    1. Leviton A, Fichorova RN, O’Shea TM, Kuban K, Paneth N, Dammann O, et al. Two-hit model of brain damage in the very preterm newborn: small for gestational age and postnatal systemic inflammation. Pediatr Res (2013) 73(3):362–70.10.1038/pr.2012.188
    1. Korzeniewski SJ, Romero R, Cortez J, Pappas A, Schwartz AG, Kim CJ, et al. A “multi-hit” model of neonatal white matter injury: cumulative contributions of chronic placental inflammation, acute fetal inflammation and postnatal inflammatory events. J Perinat Med (2014) 42(6):731–43.10.1515/jpm-2014-0250
    1. Rezaie P, Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology (2002) 22(3):106–32.10.1046/j.1440-1789.2002.00438.x
    1. Coq J-O, Delcour M, Massicotte VS, Baud O, Barbe MF. Prenatal ischemia deteriorates white matter, brain organization, and function: implications for prematurity and cerebral palsy. Dev Med Child Neurol (2016) 58:7–11.10.1111/dmcn.13040
    1. Pagnozzi AM, Dowson N, Doecke J, Fiori S, Bradley AP, Boyd RN, et al. Automated, quantitative measures of grey and white matter lesion burden correlates with motor and cognitive function in children with unilateral cerebral palsy. Neuroimage Clin (2016) 11:751–9.10.1016/j.nicl.2016.05.018
    1. Linsell L, Malouf R, Morris J, Kurinczuk JJ, Marlow N. Prognostic factors for cerebral palsy and motor impairment in children born very preterm or very low birthweight: a systematic review. Dev Med Child Neurol (2016) 58(6):554–69.10.1111/dmcn.12972
    1. Basilious A, Yager J, Fehlings MG. Neurological outcomes of animal models of uterine artery ligation and relevance to human intrauterine growth restriction: a systematic review. Dev Med Child Neurol (2015) 57(5):420–30.10.1111/dmcn.12599
    1. Johnson JWC, Austin KL, Jones GS, Davis GH, King TM. Efficacy of 17α-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med (1975) 293:675–80.10.1056/NEJM197510022931401
    1. Yemini M, Borenstein R, Dreazen E, Apelman Z, Mogilner BM, Kessler I, et al. Prevention of premature labor by 17α-hydroxyprogesterone caproate. Am J Obstet Gynecol (1985) 151(5):574–7.10.1016/0002-9378(85)90141-3
    1. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med (2009) 348:2379–85.10.1056/NEJMoa035140
    1. De Franco EA, O’Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol (2007) 30(5):697–705.10.1002/uog.5159
    1. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol (2011) 38(1):18–31.10.1002/uog.9017
    1. Da Fonseca EB, Bittar RE, Carvalho MHB, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol (2003) 188(2):419–24.10.1067/mob.2003.41
    1. Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O’Brien JM, Cetingoz E, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol (2012) 206(2):124.e1–19.10.1016/j.ajog.2011.12.003
    1. Owen J, Hankins G, Iams JD, Berghella V, Sheffield JS, Perez-Delboy A, et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol (2009) 201(4):375.e1–8.10.1016/j.ajog.2009.08.015
    1. Conde-Agudelo A, Romero R, Nicolaides K, Chaiworapongsa T, O’Brien JM, Cetingoz E, et al. Vaginal progesterone vs cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol (2013) 208(1):42.e1–18.10.1016/j.ajog.2012.10.877
    1. Goya M, Pratcorona L, Merced C, Rodó C, Valle L, Romero A, et al. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet (2012) 379(9828):1800–6.10.1016/S0140-6736(12)60030-0
    1. Alfirevic Z, Owen J, Carreras Moratonas E, Sharp AN, Szychowski JM, Goya M. Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix. Ultrasound Obstet Gynecol (2013) 41(2):146–51.10.1002/uog.12300
    1. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy a meta-analysis. Obstet Gynecol (2010) 116(2):402–14.10.1097/AOG.0b013e3181e9322a
    1. Mastrolia S, Novack L, Thachil J, Rabinovich A, Pikovsky O, Klaitman V, et al. LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia. Thromb Hemost (2016) 116(5):868–78.10.1160/TH16-02-0169
    1. Martinelli I, Ruggenenti P, Cetin I, Pardi G, Perna A, Vergani P, et al. Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood (2012) 119(14):3269–75.10.1182/blood-2011-11-391383
    1. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics (1995) 95(2):263–9.
    1. Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med (2008) 359:895–905.10.1056/NEJMoa0801187
    1. Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: a systematic review and metaanalysis. Am J Obstet Gynecol (2009) 200(6):595–609.10.1016/j.ajog.2009.04.005
    1. Costantine MM, Weiner SJ, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol (2009) 114(2 Pt 1):354–64.10.1097/AOG.0b013e3181ae98c2
    1. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev (2009) (1):CD004661.10.1002/14651858.CD004661.pub3
    1. The American College of Obstetricians and Gynecologists. Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection. Washington, DC: (2010). 455 p.
    1. Kamyar M, Manuck TA, Stoddard GJ, Varner MW, Clark E. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth. BJOG (2016) 123(7):1161–6.10.1111/1471-0528.13460
    1. Sotiriadis A, Tsiami A, Papatheodorou S, Baschat AA, Sarafidis K, Makrydimas G. Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta-analysis. Obstet Gynecol (2015) 125(6):1385–96.10.1097/AOG.0000000000000748
    1. Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med (2009) 361:1349–58.10.1056/NEJMoa0900854
    1. Edwards AD, Azzopardi DV. Therapeutic hypothermia following perinatal asphyxia. Arch Dis Child Fetal Neonatal Ed (2006) 91(2):F127–31.10.1136/adc.2005.071787
    1. Jacobs SE, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Evid Based Child Heal (2008) 3(4):1049–115.10.1002/ebch.293
    1. Porambo M, Phillips AW, Marx J, Ternes K, Arauz E, Pletnikov M, et al. Transplanted glial restricted precursor cells improve neurobehavioral and neuropathological outcomes in a mouse model of neonatal white matter injury despite limited cell survival. Glia (2015) 63(3):452–65.10.1002/glia.22764
    1. Balakrishnan B, Nance E, Johnston MV, Kannan R, Kannan S. Nanomedicine in cerebral palsy. Int J Nanomedicine (2013) 8:4183–95.10.2147/IJN.S35979
    1. Meier C, Middelanis J, Wasielewski B, Neuhoff S, Roth-Haerer A, Gantert M, et al. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res (2006) 59(2):244–9.10.1203/01.pdr.0000197309.08852.f5
    1. Min K, Song J, Kang JY, Ko J, Ryu JS, Kang MS, et al. Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial. Stem Cells (2013) 31(3):581–91.10.1002/stem.1304
    1. Shroff G. Human embryonic stem cells (hESCs) in the treatment of emphysematous COPD: a case report. Clin Case Rep (2015) 3(7):632–4.10.1002/ccr3.310
    1. Novak I, Walker K, Hunt RW, Wallace EM, Fahey M, Badawi N. Concise review: stem cell interventions for people with cerebral palsy: systematic review with meta-analysis. Stem Cells Transl Med (2016) 5(8):1014–25.10.5966/sctm.2015-0372

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere